HPV Information Center

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

Healthday More Than 14 Million Preteens Need to Receive HPV Vaccine

More Than 14 Million Preteens Need to Receive HPV Vaccine

14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.

News HPV Vaccination Decreases High-Grade Cervical Lesions in Women

HPV Vaccination Decreases High-Grade Cervical Lesions in Women

From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.

Healthday USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.

News Parental Influences on HPV Vaccination Among Low-Income Hispanic Adolescent Girls

Parental Influences on HPV Vaccination Among Low-Income Hispanic Adolescent Girls

Researchers sought to identify parental predictors of HIV vaccination in low-income adolescent Hispanic girls.

Healthday HPV Legislation Doesn't Impact Teen Sexual Behaviors

HPV Legislation Doesn't Impact Teen Sexual Behaviors

No substantive or significant associations between HPV legislation and adolescent sexual behaviors.

Healthday HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old

Less than a year following the initial direct-to-tumor vaccine injection, all treated tumors disappeared.

News HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.

Healthday HPV Cervical CA Screening Cuts Odds of Later CIN3 Diagnosis

HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis

Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing

Healthday Older Adults Increasingly Have HPV Oropharyngeal Cancers

Older Adults Increasingly Have HPV+ Oropharyngeal Cancers

Regardless of age, favorable survival conferred by an HPV-positive tumor status

Sign Up for Free e-newsletters